MySphera and the EIC Accelerator: Tracking Hospital Patients

29 September 20261,036 words6 min

MySphera, founded in Valencia in 2012 by engineers who built one of Spain's first electronic health records, tracks patients, staff and equipment inside hospitals with a real-time location system. Its software uses that data to run operating theatres and emergency departments and to tell families where a patient is.

The European Innovation Council granted €1,810,550 towards a €2.59 million project, PATHMAKER, that ran from May 2022 to April 2024. According to the CORDIS report, it halved deployment times and let the company "handle twice as many projects with the same number of staff", and it forecast "sales of 40 million euros by 2028". In February 2026 the private equity firm ABE Capital Partners acquired a majority stake for its healthcare platform Mediance; according to the deal report, MySphera's revenue was €2.32 million in 2024 and "exceeded €3 million" in 2025.

€1.81MEIC grant, 70% of a €2.59M project
-50%Deployment time, per CORDIS
290,000Patients who wore its wristbands, per deal report
€3M+Revenue in 2025

Company file

Legal entity
MySphera SL, Paterna (Valencia), Spain
Founded
January 2012, as TSB Real Time Location Systems SL
Products
ORvital for operating rooms; tools for emergency departments, asset tracking and crisis management
Reference sites
Vall d'Hebron (Barcelona), Saint-Joseph (Paris)
Owner
ABE Capital Partners (majority, February 2026), via its Mediance platform
Administrator
Essentia Health Project SL, since March 2026
Auditor
Ernst & Young
EIC project
PATHMAKER, 1 May 2022 to 30 Apr 2024, closed
EIC funding
Blended finance

Where MySphera Stands Today

MySphera's website says "more than 50 european hospitals are using our solutions" and that its first deployment was "the largest RTLS installation in Europe at the time". The register shows a capital increase of €356,229 in August 2025, bringing share capital to €1.38 million, and in March 2026 a change from a board of directors to a single administrator, Essentia Health Project SL, a Barcelona consulting and project management company founded in 2019. That change followed the sale: on 17 February 2026 Capital Riesgo reported that ABE Capital Partners had bought a majority stake to expand its healthcare platform Mediance, with the chief executive and other minority investors reinvesting, and with Swanlaab Venture Factory, Sabadell Venture Capital, Air Liquide's ALIAD and Wayra selling. The report says MySphera had been deployed in "over 60 projects across hospitals in Spain", that 290,000 patients had used its smart wristbands, and that it was profitable at EBITDA and net level by the end of 2024. The price was not disclosed.

The money

Revenue versus the forecast

Revenue reported at the time of the 2026 sale, against the EIC project report's forecast of €40 million in sales by 2028. The 2025 figure "exceeded €3 million"; €3 million is shown.

Capital Riesgo, February 2026; CORDIS project 190198323 results. Values in € millions.

The Technology: Designing a Patient's Path

PATHMAKER is a design tool for the pathways patients follow through a hospital. CORDIS reports it was used to design solutions for surgical blocks, emergency departments and endoscopy units, includes a "Demand Planner Designer" that can "optimize surgical block capacity by up to 15%", and pairs with a location system with "precision below the meter". At Saint-Joseph Hospital in Paris, which performs over 20,000 operations a year in 22 theatres, MySphera and Air Liquide equipped the ambulatory surgery unit, including screens and an app telling relatives a patient's status.

"Handle twice as many projects with the same number of staff."

PATHMAKER report, CORDIS

What the EIC Project Promised, and What CORDIS Shows

The EIC project

The EU paid 70% of a €2.59M project

PATHMAKER ran from May 2022 to April 2024. The award was blended finance.

CORDIS project 190198323. Values in € millions.

The project promised an "AI-powered visual assistive design IoT pathway platform" for fast, automated patient pathways. CORDIS reports the platform built, two peer-reviewed papers, an award at the European Healthcare Design Congress 2023 and a Value-Based Healthcare Prize finalist place in 2024. It does not give the number of hospitals using PATHMAKER.

  1. A pathway design platformDeliveredThree hospital settings.
  2. Faster deploymentDeliveredHalved, per CORDIS.
  3. Scientific validationDeliveredTwo papers.
  4. Sales growthNot shown€3M+ in 2025, vs €40M forecast.

What Has Happened Since the Award

The record

From patient tracking to a private equity sale

MySphera built its PATHMAKER design platform during the EIC project, was reported profitable by the Capital Riesgo deal report and was bought by ABE Capital Partners in 2026.

  1. Jan 2012FoundedAs TSB Real Time Location Systems SL, Valencia
  2. Oct 2021EIC Accelerator cut-offPATHMAKER: AI-assisted design of patient pathways
  3. May 2022EIC project startsPathway and demand planning tools€1.81M grant
  4. 2023AwardEuropean Healthcare Design Congress
  5. Apr 2024EIC project endsDeployment times halved, per CORDIS
  6. Aug 2025Capital increaseShare capital up 35% to €1.38M
  7. Feb 2026AcquiredABE Capital Partners takes a majority for its Mediance platform
  8. Mar 2026New governanceEssentia Health Project SL named sole administrator

MySphera, CORDIS, Capital Riesgo and Spanish register data via Empresia.

The Money

The award was blended finance; we found no public record of an EIC Fund investment, and the EIC Fund is not among the investors named as selling in 2026. Before the sale MySphera was backed by Swanlaab, Sabadell Venture Capital, ALIAD and Wayra. The August 2025 capital increase added 35% to share capital. Its accounts are audited by Ernst & Young.

What cannot be checked

What ABE Capital paid, whether the EIC Fund ever invested, and how many hospitals use PATHMAKER itself are not public.

Why Europe Should Care

MySphera's tools aim to raise operating theatre capacity, by up to 15% according to CORDIS. The EIC funded a project that, by the company's account, made them faster to install; revenue grew to more than €3 million by 2025, and the private equity firm ABE Capital Partners took a majority stake in 2026.

What the project promised

A platform for fast, automated patient pathways, and €40M in sales by 2028.

What the record shows

The platform built, deployment halved, revenue above €3M in 2025, profitability per the deal report and a sale to ABE Capital.

The Verdict

Delivered, reported profitable, sold

CORDIS reports that PATHMAKER met its technical goals, and the deal report says MySphera was profitable when private equity bought a majority stake in 2026. Its revenue of just over €3 million is still a fraction of the €40 million the project forecast for 2028.

MySphera has not been asked for comment for this article. It is based entirely on company statements, a published deal report, EU project data and Spanish register information, linked throughout.

Industry

HealthDigital health

Focus
  • Clinical software
Technologies
  • Satellite positioning
  • Artificial intelligence
Keywords
  • Patient flow
  • Operating rooms
  • Emergency departments
  • Asset tracking
  • Real-time location systems